Variable | OR | 95% Confidence limits | p Value | |
Demographic data | ||||
Female gender | 0.82 | 0.77 | 0.88 | <0.0001 |
Age | 1.01 | 1.00 | 1.01 | 0.0003 |
BMI | 0.96 | 0.96 | 0.97 | <0.0001 |
Western Europe | 1.29 | 1.20 | 1.40 | <0.0001 |
University education | 1.16 | 1.06 | 1.27 | 0.0014 |
Atherothrombotic disease location | ||||
CAD | 1.18 | 1.09 | 1.28 | <0.0001 |
CVD | 0.80 | 0.74 | 0.86 | <0.0001 |
PAD | 0.63 | 0.58 | 0.69 | <0.0001 |
Polyvascular disease (two among CAD, CVD and PAD)* | 0.82 | 0.77 | 0.88 | <0.0001 |
Physician specialty (vs GP) | ||||
Internist | 0.95 | 0.87 | 1.05 | 0.3120 |
Cardiologist | 0.95 | 0.87 | 1.04 | 0.2947 |
Vascular medicine | 0.50 | 0.44 | 0.57 | <0.0001 |
Vascular surgeon | 0.48 | 0.40 | 0.57 | <0.0001 |
Neurologist | 0.54 | 0.48 | 0.60 | <0.0001 |
Endocrinologist | 1.04 | 0.86 | 1.25 | 0.6996 |
Medical treatment | ||||
At least one antithrombotic agent | 1.59 | 1.40 | 1.80 | <0.0001 |
At least one lipid-lowering agent | 1.16 | 1.08 | 1.24 | <0.0001 |
Antidiabetic agent | 0.56 | 0.53 | 0.60 | <0.0001 |
Cardiovascular risk factors are considered controlled when at the following target levels: systolic blood pressure <140 mm Hg, diastolic blood pressure <90 mm Hg, glycaemia <1.1 g/l, total cholesterol <2.0 g/l, non-smoking; ‘good control’, 3–5 risk factors at target.
↵* Polyvascular disease was tested in a separate model not containing coronary artery disease (CAD), cardiovascular disease (CVD) and peripheral artery disease (PAD), due to polyvascular disease being a composed variable. All other variables remained in the initial model.
BMI, body mass index; GP, general practitioner.